Ongoing Projects

Discover our studies and give a look to inclusion criteria

Filter for:
Fondazione Gono logo

TRINITY

TRINITY is a multicentre, randomized, open-label, interventional phase II study aimed at…


Read More

Fondazione Gono logo

HAITI

The standard treatment for patients with Colorectal Liver Metastases unsuitable for radical liver…


Read More

Fondazione Gono logo

UNICORN

UNICORN is a Phase II, multicentre, window-of-opportunity umbrella platform trial aimed at…


Read More

Fondazione Gono logo

PURITY

PURITY is a no-profit, multicentre, randomized adaptive phase II/III trial aimed at improving…


Read More

Fondazione Gono logo

Mercury

The Merkel cell carcinoma (MCC) is an extremely rare cutaneous epithelial malignancy with highly…


Read More

Erase CRC logo

ERASE CRC

Stage III colorectal cancer (CRC) patients are currently treated with three- or sixmonths of…


Read More

Fondazione Gono logo
Accrual completed

Infinity

INFINITY is a Phase II, multicentre, single-arm, multi-cohort trial aimed at evaluating the…


Read More

Fondazione Gono logo

Realkey

80% of Head and Neck Squamous Cell Carcinoma (HNSCC) patients present advanced disease at diagnosis…


Read More

Parere logo

PARERE

The association of doublet chemotherapy (FOLFOX and FOLFIRI) and anti-EGFR moAbs (panitumumab or…


Read More

Fondazione Gono logo
Accrual completed

ShorTRIP

The standard treatment for locally advanced rectal cancer (LARC) patients is based on neoadjuvant…


Read More

TriComB logo

TriComB

5-Fluorouracil or capecitabine plus bevacizumab are recommended by major international guidelines…


Read More

Fondazione Gono logo

Point

Nasopharyngeal carcinoma (NPC) is an uncommon cancer in Europe where the incidence is well below…


Read More

Fondazione Gono logo

Sonibec

Basal Cell Carcinoma (BCC) is the most common cancer in white-skinned people with increasing…


Read More

Fondazione Gono logo

Sancuso

80% of Head and neck cancer (HNC) are diagnosed at a locally/advanced stage.


Read More

Fondazione Gono logo

Prime

80% of Head and Neck Squamous Cell Carcinoma are diagnosed at a locally/advanced stage.


Read More

Participating centers

Find
Find out some of the most recent publications from our group
Explore